Verve Therapeutics Inc (NASDAQ: VERV) May Be Attracting Institutional Investments

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

Verve Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Verve Therapeutics Inc is $527.33M. A total of 1.73 million shares were traded on the day, compared to an average of 1.35M shares.

In the most recent transaction, Ashe Andrew D. bought 76,000 shares of VERV for 6.26 per share on May 14 ’24. After the transaction, the insider now owns 342,509 company shares. In a previous transaction on Apr 02 ’24, Nickerson Joan sold 1,514 shares at 8.24 per share. VERV shares that Chief Administrative Officer owns now total 8,659.

Among the insiders who sold shares, Dorval Allison disposed of 554 shares on Nov 29 ’23 at a per-share price of $11.45. This resulted in the Chief Financial Officer holding 4,060 shares of VERV after the transaction.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, VERV has a high of $21.04 and a low of $4.59.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. VERV’s latest balance sheet shows that the firm has $360.44M in Cash & Short Term Investments as of fiscal 2021. There were $1.96M in debt and $22.02M in liabilities at the time. Its Book Value Per Share was $6.96, while its Total Shareholder’s Equity was $357.35M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VERV is Buy with a score of 4.25.

Most Popular

Related Posts